Myfembree
Active substance: RELUGOLIX, ESTRADIOL HEMIHYDRATE, NORETHINDRONE ACETATE
TABLET, FILM COATED · RELUGOLIX 40 mg/1, ESTRADIOL HEMIHYDRATE 1 mg/1, NORETHINDRONE ACETATE .5 mg/1
United StatesActive
Marketing holder: Sumitomo Pharma America, Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- RELUGOLIX · 40 mg/1
- ESTRADIOL HEMIHYDRATE · 1 mg/1
- NORETHINDRONE ACETATE · .5 mg/1
Products containing relugolix in other countries
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12099-db41-7e55-99fe-83a0651e2f64;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 72974-415
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 72974-415 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 72974-415 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 72974-415 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 72974-415 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 72974-415 · Verified 2026-10-09 · open in source